Pandemic Puts A Spotlight On Counterfeit Drugs
Is On-Dose Authentication The Answer?
Executive Summary
As the ongoing COVID-19 pandemic forces health care to go digital, opportunities for fraud have proliferated. In Vivo explores the risks, the steps regulators are taking and how companies are looking to provide innovative solutions to help secure manufacturing supply chains.